Status:
COMPLETED
Long-term Follow-up of Patients Included in the EYE-TAR(MA) Study.
Lead Sponsor:
Association de Recherche Bibliographique pour les Neurosciences
Collaborating Sponsors:
Centre Hospitalier Princesse Grace
Conditions:
Alzheimer's Dementia (AD)
Family Caregivers
Eligibility:
All Genders
18+ years
Brief Summary
EYE-TAR(MA)-Follow-Up is a non-interventionel, long-term follow-up study in subjects who participated to the study referred as EYE-TAR(MA) (NCT04730440) EYE-TAR(MA)-Follow-Up aims to evaluate the lon...
Detailed Description
It is commonly admitted that social cognition impairment, like deficit in facial emotion recognition or misinterpretation of others' intentions (Theory of Mind), are associated with social behavior di...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subjects who were included in the EYE-TAR (MA) study, and who completed this study.
- Subject accompanied by the caregiver already present during participation in the EYE-TAR (MA) study.
- Written informed consent signed by patient and family caregiver.
Exclusion
Key Trial Info
Start Date :
January 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 11 2022
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT05254873
Start Date
January 21 2022
End Date
April 11 2022
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Mémoire / Centre de Gérontologie Clinique Rainier III / Princess Grace Hospital
Monaco, Monaco, 98000